Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage

Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of pathology 2004-11, Vol.165 (5), p.1603-1612
Hauptverfasser: Kawai, Hanayo, Sato, Waichi, Yuzawa, Yukio, Kosugi, Tomoki, Matsuo, Seiichi, Takei, Yoshifumi, Kadomatsu, Kenji, Muramatsu, Takashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1612
container_issue 5
container_start_page 1603
container_title The American journal of pathology
container_volume 165
creator Kawai, Hanayo
Sato, Waichi
Yuzawa, Yukio
Kosugi, Tomoki
Matsuo, Seiichi
Takei, Yoshifumi
Kadomatsu, Kenji
Muramatsu, Takashi
description Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.
doi_str_mv 10.1016/S0002-9440(10)63417-7
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002944010634177</els_id><sourcerecordid>15509530</sourcerecordid><originalsourceid>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</originalsourceid><addsrcrecordid>eNqFkc1uEzEURi0EomnLI4C8QcBiqO947JnZFKHQlkqpKlHYsLFu_JNxO_FE9iRV3x6niVpYsbLse77P1jEhb4F9Bgby5IYxVhZtVbGPwD5JXkFd1C_IBEQpihJaeEkmT8gBOUzpNm8lb9hrcgBCsFZwNiG_Z6jv6ODo2Fl6EYf7saPnqMch0itv7nyw9Cx0GLRN9GYdN36DPcUF-pBGOvVp1ePoQ3EZzFpbQ3_YkOffcIkLe0xeOeyTfbNfj8iv87Of0-_F7Pricvp1VmjRwliIlstGiLkzJVruGHBhmqaR85oDkygdOGxlM3ecMe00B1O1ludJ6ZyrOPIjcrrrXa3nS2u0DWPEXq2iX2J8UAN69e8k-E4tho0CCY2sq1wgdgU6DilF656ywNRWtnqUrbYmt0ePslWdc-_-vvg5tbebgfd7AJPG3sXs0adnTpa8FLLJ3Icd1_lFd--jVWmJfZ9rQeHtCqRQItOMZ_LLjrRZ6MbbqJL2Nv-OySk9KjP4_zz6D6amqdk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</creator><creatorcontrib>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</creatorcontrib><description>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</description><identifier>ISSN: 0002-9440</identifier><identifier>EISSN: 1525-2191</identifier><identifier>DOI: 10.1016/S0002-9440(10)63417-7</identifier><identifier>PMID: 15509530</identifier><identifier>CODEN: AJPAA4</identifier><language>eng</language><publisher>Bethesda, MD: Elsevier Inc</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Biological and medical sciences ; Blood Urea Nitrogen ; Blotting, Northern ; Blotting, Western ; Cell Survival ; Cisplatin - adverse effects ; Cytokines - genetics ; Cytokines - physiology ; Enzyme-Linked Immunosorbent Assay ; Fibroblasts - metabolism ; Genetic Predisposition to Disease ; In Situ Nick-End Labeling ; Inflammation ; Investigative techniques, diagnostic techniques (general aspects) ; Kidney - drug effects ; Kidney - injuries ; Kidney - pathology ; Medical sciences ; Mice ; Mice, Transgenic ; Neutrophils - metabolism ; Neutrophils - pathology ; Oligonucleotides, Antisense - chemistry ; Oligonucleotides, Antisense - pharmacology ; Original Research Paper ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Ribonucleases - metabolism ; Time Factors ; Treatment Outcome</subject><ispartof>The American journal of pathology, 2004-11, Vol.165 (5), p.1603-1612</ispartof><rights>2004 American Society for Investigative Pathology</rights><rights>2004 INIST-CNRS</rights><rights>Copyright © American Society for Investigative Pathology 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</citedby><cites>FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618674/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9440(10)63417-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27903,27904,45974,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16232568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15509530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawai, Hanayo</creatorcontrib><creatorcontrib>Sato, Waichi</creatorcontrib><creatorcontrib>Yuzawa, Yukio</creatorcontrib><creatorcontrib>Kosugi, Tomoki</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Takei, Yoshifumi</creatorcontrib><creatorcontrib>Kadomatsu, Kenji</creatorcontrib><creatorcontrib>Muramatsu, Takashi</creatorcontrib><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><title>The American journal of pathology</title><addtitle>Am J Pathol</addtitle><description>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Blood Urea Nitrogen</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Cell Survival</subject><subject>Cisplatin - adverse effects</subject><subject>Cytokines - genetics</subject><subject>Cytokines - physiology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fibroblasts - metabolism</subject><subject>Genetic Predisposition to Disease</subject><subject>In Situ Nick-End Labeling</subject><subject>Inflammation</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Kidney - drug effects</subject><subject>Kidney - injuries</subject><subject>Kidney - pathology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - pathology</subject><subject>Oligonucleotides, Antisense - chemistry</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Original Research Paper</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Ribonucleases - metabolism</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0002-9440</issn><issn>1525-2191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1uEzEURi0EomnLI4C8QcBiqO947JnZFKHQlkqpKlHYsLFu_JNxO_FE9iRV3x6niVpYsbLse77P1jEhb4F9Bgby5IYxVhZtVbGPwD5JXkFd1C_IBEQpihJaeEkmT8gBOUzpNm8lb9hrcgBCsFZwNiG_Z6jv6ODo2Fl6EYf7saPnqMch0itv7nyw9Cx0GLRN9GYdN36DPcUF-pBGOvVp1ePoQ3EZzFpbQ3_YkOffcIkLe0xeOeyTfbNfj8iv87Of0-_F7Pricvp1VmjRwliIlstGiLkzJVruGHBhmqaR85oDkygdOGxlM3ecMe00B1O1ludJ6ZyrOPIjcrrrXa3nS2u0DWPEXq2iX2J8UAN69e8k-E4tho0CCY2sq1wgdgU6DilF656ywNRWtnqUrbYmt0ePslWdc-_-vvg5tbebgfd7AJPG3sXs0adnTpa8FLLJ3Icd1_lFd--jVWmJfZ9rQeHtCqRQItOMZ_LLjrRZ6MbbqJL2Nv-OySk9KjP4_zz6D6amqdk</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Kawai, Hanayo</creator><creator>Sato, Waichi</creator><creator>Yuzawa, Yukio</creator><creator>Kosugi, Tomoki</creator><creator>Matsuo, Seiichi</creator><creator>Takei, Yoshifumi</creator><creator>Kadomatsu, Kenji</creator><creator>Muramatsu, Takashi</creator><general>Elsevier Inc</general><general>ASIP</general><general>American Society for Investigative Pathology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20041101</creationdate><title>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</title><author>Kawai, Hanayo ; Sato, Waichi ; Yuzawa, Yukio ; Kosugi, Tomoki ; Matsuo, Seiichi ; Takei, Yoshifumi ; Kadomatsu, Kenji ; Muramatsu, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c591t-5936855bfd2ae3f0135d8886b73106a6f1fa968bf300cfc31d49e306a2fff43a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Blood Urea Nitrogen</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Cell Survival</topic><topic>Cisplatin - adverse effects</topic><topic>Cytokines - genetics</topic><topic>Cytokines - physiology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fibroblasts - metabolism</topic><topic>Genetic Predisposition to Disease</topic><topic>In Situ Nick-End Labeling</topic><topic>Inflammation</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Kidney - drug effects</topic><topic>Kidney - injuries</topic><topic>Kidney - pathology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - pathology</topic><topic>Oligonucleotides, Antisense - chemistry</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Original Research Paper</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Ribonucleases - metabolism</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawai, Hanayo</creatorcontrib><creatorcontrib>Sato, Waichi</creatorcontrib><creatorcontrib>Yuzawa, Yukio</creatorcontrib><creatorcontrib>Kosugi, Tomoki</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Takei, Yoshifumi</creatorcontrib><creatorcontrib>Kadomatsu, Kenji</creatorcontrib><creatorcontrib>Muramatsu, Takashi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawai, Hanayo</au><au>Sato, Waichi</au><au>Yuzawa, Yukio</au><au>Kosugi, Tomoki</au><au>Matsuo, Seiichi</au><au>Takei, Yoshifumi</au><au>Kadomatsu, Kenji</au><au>Muramatsu, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage</atitle><jtitle>The American journal of pathology</jtitle><addtitle>Am J Pathol</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>165</volume><issue>5</issue><spage>1603</spage><epage>1612</epage><pages>1603-1612</pages><issn>0002-9440</issn><eissn>1525-2191</eissn><coden>AJPAA4</coden><abstract>Although cisplatin acts directly on proximal tubule epithelial cells and causes cell death, little is known regarding the biological significance of its secondary effects, such as inflammation. The growth factor midkine is highly expressed in the proximal tubule and exerts ambivalent activities as to cisplatin nephrotoxicity, ie, anti-apoptotic and chemotactic ones. Here we report that midkine-deficient mice show a significantly higher survival rate than wild-type mice. The levels of blood urea nitrogen and tubular degeneration and apoptosis were higher in wild-type mice despite the anti-apoptotic activity of midkine. We found that recruitment of neutrophils was more enhanced in wild-type mice, this being consistent with the chemotactic activity of midkine. Midkine expression in wild-type mice persisted for 24 hours, and then dramatically decreased. Preadministration of midkine anti-sense oligodeoxyribonucleotide to wild-type mice suppressed midkine expression, and consequently neutrophil infiltration. It is of note that neutrophil infiltration, apoptosis, and elevation of blood urea nitrogen became conspicuous sequentially, namely 1, 2, and 3 days after cisplatin administration, respectively. These findings suggest that early molecular events involving midkine induce inflammatory response and their circuits eventually enhance the death of the proximal tubule epithelial cells. The results indicate the crucial role of inflammation in cisplatin-induced renal damage, and provide a candidate molecular target for its prevention.</abstract><cop>Bethesda, MD</cop><pub>Elsevier Inc</pub><pmid>15509530</pmid><doi>10.1016/S0002-9440(10)63417-7</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9440
ispartof The American journal of pathology, 2004-11, Vol.165 (5), p.1603-1612
issn 0002-9440
1525-2191
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618674
source MEDLINE; Elsevier ScienceDirect Journals Complete; PubMed Central; EZB Electronic Journals Library
subjects Animals
Antineoplastic Agents - pharmacology
Apoptosis
Biological and medical sciences
Blood Urea Nitrogen
Blotting, Northern
Blotting, Western
Cell Survival
Cisplatin - adverse effects
Cytokines - genetics
Cytokines - physiology
Enzyme-Linked Immunosorbent Assay
Fibroblasts - metabolism
Genetic Predisposition to Disease
In Situ Nick-End Labeling
Inflammation
Investigative techniques, diagnostic techniques (general aspects)
Kidney - drug effects
Kidney - injuries
Kidney - pathology
Medical sciences
Mice
Mice, Transgenic
Neutrophils - metabolism
Neutrophils - pathology
Oligonucleotides, Antisense - chemistry
Oligonucleotides, Antisense - pharmacology
Original Research Paper
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Ribonucleases - metabolism
Time Factors
Treatment Outcome
title Lack of the Growth Factor Midkine Enhances Survival against Cisplatin-Induced Renal Damage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T16%3A24%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20the%20Growth%20Factor%20Midkine%20Enhances%20Survival%20against%20Cisplatin-Induced%20Renal%20Damage&rft.jtitle=The%20American%20journal%20of%20pathology&rft.au=Kawai,%20Hanayo&rft.date=2004-11-01&rft.volume=165&rft.issue=5&rft.spage=1603&rft.epage=1612&rft.pages=1603-1612&rft.issn=0002-9440&rft.eissn=1525-2191&rft.coden=AJPAA4&rft_id=info:doi/10.1016/S0002-9440(10)63417-7&rft_dat=%3Cpubmed_cross%3E15509530%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15509530&rft_els_id=S0002944010634177&rfr_iscdi=true